Annual EBITDA:
-$43.00M+$3.53M(+7.59%)Summary
- As of today, AVXL annual EBITDA is -$43.00 million, with the most recent change of +$3.53 million (+7.59%) on September 30, 2024.
- During the last 3 years, AVXL annual EBITDA has fallen by -$5.36 million (-14.24%).
- AVXL annual EBITDA is now -296465.52% below its all-time high of -$14.50 thousand, reached on September 30, 2004.
Performance
AVXL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$14.46M-$1.95M(-15.55%)Summary
- As of today, AVXL quarterly EBITDA is -$14.46 million, with the most recent change of -$1.95 million (-15.55%) on June 30, 2025.
- Over the past year, AVXL quarterly EBITDA has increased by +$144.00 thousand (+0.99%).
- AVXL quarterly EBITDA is now -352558.54% below its all-time high of -$4100.00, reached on December 31, 2004.
Performance
AVXL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$54.90M+$144.00K(+0.26%)Summary
- As of today, AVXL TTM EBITDA is -$54.90 million, with the most recent change of +$144.00 thousand (+0.26%) on June 30, 2025.
- Over the past year, AVXL TTM EBITDA has dropped by -$3.64 million (-7.11%).
- AVXL TTM EBITDA is now -1338924.39% below its all-time high of -$4100.00, reached on December 31, 2004.
Performance
AVXL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AVXL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +7.6% | +1.0% | -7.1% |
| 3Y3 Years | -14.2% | -16.1% | -14.5% |
| 5Y5 Years | -49.3% | -78.4% | -76.6% |
AVXL EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +9.7% | -27.1% | +6.0% | -9.4% | +6.0% |
| 5Y | 5-Year | -39.0% | +9.7% | -92.6% | +6.0% | -76.6% | +6.0% |
| All-Time | All-Time | >-9999.0% | +9.7% | >-9999.0% | +6.0% | >-9999.0% | +6.0% |
AVXL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$14.46M(-15.6%) | -$54.90M(+0.3%) |
| Mar 2025 | - | -$12.51M(+7.9%) | -$55.04M(+0.2%) |
| Dec 2024 | - | -$13.59M(+5.2%) | -$55.16M(-4.2%) |
| Sep 2024 | -$43.00M(+7.6%) | -$14.34M(+1.8%) | -$52.94M(-3.3%) |
| Jun 2024 | - | -$14.60M(-15.7%) | -$51.26M(-2.1%) |
| Mar 2024 | - | -$12.62M(-11.0%) | -$50.19M(+3.0%) |
| Dec 2023 | - | -$11.38M(+10.1%) | -$51.75M(+7.2%) |
| Sep 2023 | -$46.53M(+2.3%) | -$12.65M(+6.5%) | -$55.76M(+4.5%) |
| Jun 2023 | - | -$13.53M(+4.6%) | -$58.39M(-1.9%) |
| Mar 2023 | - | -$14.19M(+7.8%) | -$57.32M(-4.9%) |
| Dec 2022 | - | -$15.38M(-0.7%) | -$54.65M(-7.2%) |
| Sep 2022 | -$47.62M(-26.5%) | -$15.28M(-22.7%) | -$50.99M(-6.3%) |
| Jun 2022 | - | -$12.46M(-8.2%) | -$47.95M(-2.3%) |
| Mar 2022 | - | -$11.52M(+1.7%) | -$46.89M(-5.8%) |
| Dec 2021 | - | -$11.72M(+4.3%) | -$44.33M(-5.5%) |
| Sep 2021 | -$37.64M(-21.7%) | -$12.25M(-7.5%) | -$42.00M(-12.7%) |
| Jun 2021 | - | -$11.40M(-27.3%) | -$37.26M(-9.7%) |
| Mar 2021 | - | -$8.95M(+4.7%) | -$33.97M(-3.6%) |
| Dec 2020 | - | -$9.40M(-25.2%) | -$32.78M(-5.5%) |
| Sep 2020 | -$30.94M(-7.4%) | -$7.51M(+7.4%) | -$31.09M(-3.9%) |
| Jun 2020 | - | -$8.11M(-4.3%) | -$29.93M(-3.3%) |
| Mar 2020 | - | -$7.77M(-0.9%) | -$28.97M(+1.3%) |
| Dec 2019 | - | -$7.70M(-21.3%) | -$29.33M(-0.8%) |
| Sep 2019 | -$28.81M(-50.2%) | -$6.35M(+11.2%) | -$29.11M(-1.6%) |
| Jun 2019 | - | -$7.15M(+12.2%) | -$28.65M(-33.2%) |
| Mar 2019 | - | -$8.14M(-8.9%) | -$21.50M(-18.8%) |
| Dec 2018 | - | -$7.47M(-26.9%) | -$18.10M(-23.0%) |
| Sep 2018 | -$19.18M(-23.5%) | -$5.89M(-24.4%) | -$14.72M(+17.0%) |
| Mar 2018 | - | -$4.73M(-15.7%) | -$17.73M(-6.8%) |
| Dec 2017 | - | -$4.09M(+21.3%) | -$16.60M(-5.9%) |
| Sep 2017 | -$15.54M(-0.6%) | -$5.20M(-40.3%) | -$15.68M(+8.1%) |
| Jun 2017 | - | -$3.71M(-2.7%) | -$17.07M(-9.0%) |
| Mar 2017 | - | -$3.61M(-13.9%) | -$15.65M(-10.0%) |
| Dec 2016 | - | -$3.17M(+51.9%) | -$14.22M(+8.7%) |
| Sep 2016 | -$15.45M(-28.3%) | -$6.58M(-187.0%) | -$15.59M(-20.2%) |
| Jun 2016 | - | -$2.29M(-5.2%) | -$12.97M(-6.4%) |
| Mar 2016 | - | -$2.18M(+51.9%) | -$12.19M(-12.2%) |
| Dec 2015 | - | -$4.53M(-14.3%) | -$10.87M(-52.9%) |
| Sep 2015 | -$12.04M | -$3.97M(-162.2%) | -$7.11M(-88.0%) |
| Jun 2015 | - | -$1.51M(-76.3%) | -$3.78M(-15.7%) |
| Mar 2015 | - | -$858.10K(-11.4%) | -$3.27M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | - | -$770.40K(-20.5%) | -$3.43M(-15.6%) |
| Sep 2014 | -$2.97M(+18.6%) | -$639.20K(+36.0%) | -$2.97M(+21.8%) |
| Jun 2014 | - | -$998.60K(+2.2%) | -$3.80M(-29.9%) |
| Mar 2014 | - | -$1.02M(-230.7%) | -$2.92M(-44.1%) |
| Dec 2013 | - | -$308.70K(+79.0%) | -$2.03M(+5.0%) |
| Sep 2013 | -$3.65M(+54.8%) | -$1.47M(-1071.9%) | -$2.14M(-63.3%) |
| Jun 2013 | - | -$125.30K(+0.8%) | -$1.31M(+29.6%) |
| Mar 2013 | - | -$126.30K(+69.6%) | -$1.86M(+25.0%) |
| Dec 2012 | - | -$415.40K(+35.2%) | -$2.48M(+41.3%) |
| Sep 2012 | -$8.06M(-30.7%) | -$640.90K(+5.2%) | -$4.22M(+13.7%) |
| Jun 2012 | - | -$675.80K(+9.5%) | -$4.89M(+16.4%) |
| Mar 2012 | - | -$747.00K(+65.4%) | -$5.85M(+17.0%) |
| Dec 2011 | - | -$2.16M(-64.8%) | -$7.05M(-12.5%) |
| Sep 2011 | -$6.17M(-9.3%) | -$1.31M(+19.9%) | -$6.27M(+14.9%) |
| Jun 2011 | - | -$1.63M(+16.0%) | -$7.36M(-4.7%) |
| Mar 2011 | - | -$1.95M(-41.2%) | -$7.03M(-6.5%) |
| Dec 2010 | - | -$1.38M(+42.7%) | -$6.60M(-8.5%) |
| Sep 2010 | -$5.65M(-19.3%) | -$2.41M(-84.8%) | -$6.08M(-11.0%) |
| Jun 2010 | - | -$1.30M(+14.2%) | -$5.48M(-0.8%) |
| Mar 2010 | - | -$1.52M(-76.3%) | -$5.44M(-15.9%) |
| Dec 2009 | - | -$860.70K(+52.2%) | -$4.69M(+1.0%) |
| Sep 2009 | -$4.73M(+10.2%) | -$1.80M(-43.3%) | -$4.73M(+11.0%) |
| Jun 2009 | - | -$1.26M(-63.2%) | -$5.32M(+1.0%) |
| Mar 2009 | - | -$769.90K(+15.0%) | -$5.37M(-2.1%) |
| Dec 2008 | - | -$905.80K(+62.0%) | -$5.26M(+0.2%) |
| Sep 2008 | -$5.27M(-234.0%) | -$2.38M(-82.1%) | -$5.27M(-30.8%) |
| Jun 2008 | - | -$1.31M(-98.6%) | -$4.03M(-35.5%) |
| Mar 2008 | - | -$659.60K(+28.0%) | -$2.97M(-19.8%) |
| Dec 2007 | - | -$915.50K(+19.9%) | -$2.48M(-57.2%) |
| Sep 2007 | -$1.58M(-6063.7%) | -$1.14M(-350.2%) | -$1.58M(-257.8%) |
| Jun 2007 | - | -$253.90K(-50.1%) | -$441.10K(-128.7%) |
| Mar 2007 | - | -$169.20K(-1275.6%) | -$192.90K(-579.2%) |
| Dec 2006 | - | -$12.30K(-115.8%) | -$28.40K(-11.4%) |
| Sep 2006 | -$25.60K(+72.1%) | -$5700.00(0.0%) | -$25.50K(+41.1%) |
| Jun 2006 | - | -$5700.00(-21.3%) | -$43.30K(+22.8%) |
| Mar 2006 | - | -$4700.00(+50.0%) | -$56.10K(+42.2%) |
| Dec 2005 | - | -$9400.00(+60.0%) | -$97.10K(-5.8%) |
| Sep 2005 | -$91.70K(-532.4%) | -$23.50K(-27.0%) | -$91.80K(-34.4%) |
| Jun 2005 | - | -$18.50K(+59.5%) | -$68.30K(-37.1%) |
| Mar 2005 | - | -$45.70K(-1014.6%) | -$49.80K(-1114.6%) |
| Dec 2004 | - | -$4100.00 | -$4100.00 |
| Sep 2004 | -$14.50K | - | - |
FAQ
- What is Anavex Life Sciences Corp. annual EBITDA?
- What is the all-time high annual EBITDA for Anavex Life Sciences Corp.?
- What is Anavex Life Sciences Corp. annual EBITDA year-on-year change?
- What is Anavex Life Sciences Corp. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Anavex Life Sciences Corp.?
- What is Anavex Life Sciences Corp. quarterly EBITDA year-on-year change?
- What is Anavex Life Sciences Corp. TTM EBITDA?
- What is the all-time high TTM EBITDA for Anavex Life Sciences Corp.?
- What is Anavex Life Sciences Corp. TTM EBITDA year-on-year change?
What is Anavex Life Sciences Corp. annual EBITDA?
The current annual EBITDA of AVXL is -$43.00M
What is the all-time high annual EBITDA for Anavex Life Sciences Corp.?
Anavex Life Sciences Corp. all-time high annual EBITDA is -$14.50K
What is Anavex Life Sciences Corp. annual EBITDA year-on-year change?
Over the past year, AVXL annual EBITDA has changed by +$3.53M (+7.59%)
What is Anavex Life Sciences Corp. quarterly EBITDA?
The current quarterly EBITDA of AVXL is -$14.46M
What is the all-time high quarterly EBITDA for Anavex Life Sciences Corp.?
Anavex Life Sciences Corp. all-time high quarterly EBITDA is -$4100.00
What is Anavex Life Sciences Corp. quarterly EBITDA year-on-year change?
Over the past year, AVXL quarterly EBITDA has changed by +$144.00K (+0.99%)
What is Anavex Life Sciences Corp. TTM EBITDA?
The current TTM EBITDA of AVXL is -$54.90M
What is the all-time high TTM EBITDA for Anavex Life Sciences Corp.?
Anavex Life Sciences Corp. all-time high TTM EBITDA is -$4100.00
What is Anavex Life Sciences Corp. TTM EBITDA year-on-year change?
Over the past year, AVXL TTM EBITDA has changed by -$3.64M (-7.11%)